Get started
Author

Valéria Buccheri

Observed names: Buccheri, Valeria, V Buccheri, V. Buccheri, Valeria Buccheri
Observed institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Universidade de São Paulo, Vanderbilt University, Czech Academy of Sciences, Korea Institute of Radiological and Medical Sciences, Instituto do Câncer do Estado de São Paulo, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Royal Marsden Hospital, Czech Academy of Sciences, Institute of Molecular Genetics, Hospital Universitário da Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Instituto do Coração - HCFMUSP, Maria Cecilia Souto Vidigal Foundation, Vanderbilt University Medical Center
ORCID: 0000-0002-6999-4109
Observed ORCID: 0000-0002-6999-4109
OpenAlex ID: A5019220020
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study
2021 · John Kuruvilla, Radhakrishnan Ramchandren, et al. · The Lancet Oncology · 270
Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients
2004 · Elia Ascer, Marcelo C. Bertolami, et al. · Atherosclerosis · 194
A classification of acute leukaemia for the 1990s
1991 · D. Catovsky, E. Matutes, et al. · Annals of Hematology · 189
18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma
2010 · Juliano J. Cerci, Luís F. Pracchia, et al. · Journal of Nuclear Medicine · 145
PDF
Cytogenetic findings in acute biphenotypic leukaemia.
1996 · F Carbonell, J Swansbury, et al. · PubMed · 120
Lineage commitment in biphenotypic acute leukemia.
1993 · V Buccheri, E Matutes, et al. · PubMed · 92
Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Complete Remission or Partial Remission After First-Line Therapy
2010 · Juliano J. Cerci, Evelinda Trindade, et al. · Journal of Clinical Oncology · 78
PDF
Structural and functional basis of mammalian microRNA biogenesis by Dicer
2022 · David Zapletal, Eliska Taborska, et al. · Molecular Cell · 77
PDF
The role of an anti‐myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry
1992 · V. Buccheri, V. Shetty, et al. · British Journal of Haematology · 73
mb-1: a new marker for B-lineage lymphoblastic leukemia
1993 · V Buccheri, B Mihaljevic, et al. · Blood · 62
Manual de Hematologia - Propedêutica e Clínica
2003 · Therezinha F. Lorenzi, Élbio Antônio D’Amico, et al. · 55
Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia
2016 · Celso Arrais Rodrigues, Matheus Vescovi Gonçalves, et al. · Revista Brasileira de Hematologia e Hemoterapia · 50
Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation
2018 · Valeria Buccheri, Wolney Gois Barreto, et al. · Annals of Hematology · 49
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial
2016 · Sarit Assouline, Valeria Buccheri, et al. · The Lancet Haematology · 45
Real-life Outcomes on Acute Promyelocytic Leukemia in Brazil – Early Deaths Are Still a Problem
2018 · Wellington F. da Silva, Lidiane Inês da Rosa, et al. · Clinical Lymphoma Myeloma & Leukemia · 43
Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia
2015 · Sarit Assouline, Valeria Buccheri, et al. · British Journal of Clinical Pharmacology · 41
PDF
KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).
2020 · John Kuruvilla, Radhakrishnan Ramchandren, et al. · Journal of Clinical Oncology · 33
Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin Lymphoma Across Jurisdictions
2011 · Juliano J. Cerci, Evelinda Trindade, et al. · Clinical Lymphoma Myeloma & Leukemia · 32
Gammadelta and alphabeta T-cell acute lymphoblastic leukemia: comparison of their clinical and immunophenotypic features.
2005 · Daniel Mazza Matos, Edgar Gil Rizzatti, et al. · PubMed · 31
Treating Adult Acute Lymphoblastic Leukemia in Brazil—Increased Early Mortality Using a German Multicenter Acute Lymphoblastic Leukemia-based regimen
2018 · Wellington Fernandes da Silva Junior, Andrezza Bertolaci Medina, et al. · Clinical Lymphoma Myeloma & Leukemia · 29
Hodgkin Lymphoma Among Patients Infected with HIV in Post-HAART Era
2007 · Paula Yurie Tanaka, Vicente Porfírio Pessoa, et al. · Clinical Lymphoma & Myeloma · 22
Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias
1993 · MJ Dyer, JM Heward, et al. · Blood · 21
Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy
2020 · David Straus, Graham Collins, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 19
PDF
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
2021 · Pier Luigi Zinzani, Radhakrishnan Ramchandren, et al. · Blood Advances · 18
PDF
Positron Emission Tomography With 2-[18F]-Fluoro-2-Deoxy-D-Glucose For Initial Staging Of Hodgkin Lymphoma: A Single Center Experience In Brazil
2009 · Juliano Julio Cerci, Luís Fernando Pracchia, et al. · Clinics · 18
PDF
Works count: 138
Citation count: 2,103
H-index: 21
I10-index: 35
Year
Topic
Type